A Year After Elliott Arrived, Is PepsiCo’s Turnaround Running Out of Time?
PepsiCo reported Q3 earnings beating expectations with $25.27B revenue and $2.34 EPS, but cut its 2026 EPS growth forecast to 2.5–3.5%. North American sales declined, while international growth accelerated. Shares are down 12% YTD. Elliott Management, which holds a $4B stake, is pressuring for a turnaround amid GLP-1 drug threats to snack and beverage demand.
How this was made
The 30-second read
Why it matters
The article argues the operational turnaround is behind schedule in North America, with guidance lowered and margins trending opposite the prior target path, while GLP-1 adoption adds structural demand pressure.
Market read
Traders should focus on whether North America cost reductions can restore margins without reversing the volume gains from earlier price cuts, amid heightened GLP-1 demand risk.
What to watch
Tariff refunds boosted reported core operating profit; investors may over-penalize margins if they do not normalize for that one-quarter benefit and if cost actions later offset it.
Background
Elliott Investment Management built a roughly $4B stake about a year earlier, after which PepsiCo announced price cuts, productivity savings, and a multi-year margin target.
Ticker impact
PepsiCo cut fiscal 2026 core EPS growth guidance to 2.5% to 3.5% as North America turnaround margins lag despite a Q3 revenue and EPS beat.
Likely downside or continued underperformance as investors reprice the probability of hitting the multi-year margin target given the slower North America recovery.
The article’s actionable new datapoint is the guidance cut tied directly to North America turnaround timing, with additional context that margins moved the wrong way versus the company’s prior target trajectory.
Market effects
GLP-1-driven demand risk for snacks and sugary drinks is framed as structural, reinforcing a cautious stance on packaged food volume durability and pricing power.
North America is identified as the key drag, implying regional earnings quality divergence versus International.
International growth resilience is noted, but the article emphasizes that global upside may not offset North America margin timing risk.
Counterpoint
The quarter beat on revenue and EPS and showed global organic growth acceleration, so the guidance cut may reflect conservatism rather than a broken turnaround path.
Key entities
- companyPepsiCo
Subject of the article, with Q3 results and a lowered fiscal 2026 core EPS growth outlook tied to North America turnaround timing.
- activist_investorElliott Investment Management
Activist behind the stake and the turnaround plan framework discussed in the article.
- macro_demand_factorGLP-1 weight-loss drugs
Framed as structural pressure on long-run volume expectations for snacks and sugary drinks.
